Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Asset Writedowns and Impairment (2023 - 2024)

Historic Asset Writedowns and Impairment for Pediatrix Medical (MD) over the last 2 years, with Q4 2024 value amounting to -$3.6 million.

  • Pediatrix Medical's Asset Writedowns and Impairment fell 10213.83% to -$3.6 million in Q4 2024 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year decrease of 9123.63%. This contributed to the annual value of $178.4 million for FY2024, which is 601.44% up from last year.
  • Pediatrix Medical's Asset Writedowns and Impairment amounted to -$3.6 million in Q4 2024, which was down 10213.83% from $20.1 million recorded in Q2 2024.
  • In the past 5 years, Pediatrix Medical's Asset Writedowns and Impairment ranged from a high of $168.3 million in Q4 2023 and a low of -$3.6 million during Q4 2024